# Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates

> **NCT03053076** · PHASE1 · UNKNOWN · sponsor: **Guangdong Women and Children Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Safety Issues
- Effect of Drugs
- Neonatal Death

## Interventions

- **OTHER:** Autologous Umbilical Cord Blood Mononuclear Cells Therapy
- **DRUG:** 0.9% Sodium Chloride

## Key facts

- **NCT ID:** NCT03053076
- **Lead sponsor:** Guangdong Women and Children Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-10
- **Primary completion:** 2017-05-15
- **Final completion:** 2017-05-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053076, "Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03053076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*